| For: | Sang LX. Corrigendum to “Probiotic mixture VSL#3: An overview of basic and clinical studies in chronic diseases”. World J Clin Cases 2021; 9(20): 5752-5753 [PMID: 34307635 DOI: 10.12998/wjcc.v9.i20.5752] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v9/i20/5752.htm |
| Number | Citing Articles |
| 1 |
Zvi Weizman. Use of Fecal Sampling for Assessing Probiotic Effects on the Gut Microbiome: A Focused Narrative Review. Cureus 2026; doi: 10.7759/cureus.115981
|
| 2 |
Kunyi Zhao, Zhishang Zhang, Zheng Tang, Xinai Man, Jiayi Liu, Ruiqi Feng, Kehao Li, Yaping Jiang, Tao Li. Targeting the gut–bone axis in osteoporosis: probiotic interventions and other microbiota-based therapeutic strategies. Gut Microbes 2026; 18(1) doi: 10.1080/19490976.2026.2732528
|
| 3 |
Yao Xu, Runxiang Xie, Yuqing Weng, Yewei Fang, Shuan Tao, He Zhang, Huimin Chen, Axiang Han, Qi Jiang, Wei Liang. Role and mechanism of gut microbiota-host interactions in the pathogenesis of Crohn’s disease. International Journal of Colorectal Disease 2025; 40(1) doi: 10.1007/s00384-025-04917-7
|